DCF — RESOLUTE HEALTH
Enterprise Value: $75.0M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$75.0M
Enterprise Value
$19.1M
PV of Cash Flows
$55.9M
PV of Terminal Value
$90.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $121.2M | $10.3M | 8.0% | $3.4M | $3.0M |
| Year 2 | $124.8M | $11.9M | 9.0% | $4.4M | $3.6M |
| Year 3 | $128.6M | $13.5M | 10.0% | $5.5M | $4.1M |
| Year 4 | $132.4M | $14.6M | 11.0% | $6.1M | $4.2M |
| Year 5 | $136.4M | $15.3M | 11.0% | $6.6M | $4.1M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $75.0M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$117.7M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.07999999830030854
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5